Literature DB >> 9892041

Antiinflammatory potency of dehydrocurdione, a zedoary-derived sesquiterpene.

T Yoshioka1, E Fujii, M Endo, K Wada, Y Tokunaga, N Shiba, H Hohsho, H Shibuya, T Muraki.   

Abstract

OBJECTIVE AND
DESIGN: Dehydrocurdione, a sesquiterpene isolated from zedoary, was tested for in vivo and in vitro antiinflammatory actions. MATERIALS: Analgesic effect was tested in ICR mice by the acetic acid-induced writhing method. Antipyretic effect was studied in Sprague-Dawley rats treated with baker's yeast. Antiinflammatory activities were tested in Wistar rats with carrageenan-induced paw edema and adjuvant-induced chronic arthritis. In vitro analyses included the capabilities to inhibit cyclooxygenase activity, and to scavenge free radicals as determined by electron paramagnetic resonance (EPR).
RESULTS: Oral administration of dehydrocurdione (40 to 200 mg/kg) mitigated the writhing reflex. induced by acetic acid and the fever elicited by baker's yeast. A higher dose (200 mg/kg) of dehydrocurdione was required to inhibit the carrageenan-induced paw edema. Oral administration of dehydrocurdione at 120 mg/kg/day for 12 days significantly reduced chronic adjuvant arthritis. Unlike indomethacin (IC50: 0.1 microM), dehydrocurdione showed minimal cyclooxygenase inhibition. However, dehydrocurdione (100 microM to 5 mM) significantly reduced free radical formation from hydrogen peroxide and ferrous iron determined by EPR spectrometry using 5,5'-dimethyl-1-pyrroline-N-oxide as a spin trap agent.
CONCLUSION: In addition to the well-known effect of zedoary as a stomachic, dehydrocurdione, the major component of Curcuma zedoaria Roscoe has antiinflammatory potency related to its antioxidant effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9892041     DOI: 10.1007/s000110050361

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  6 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  System-level multi-target drug discovery from natural products with applications to cardiovascular diseases.

Authors:  Chunli Zheng; Jinan Wang; Jianling Liu; Mengjie Pei; Chao Huang; Yonghua Wang
Journal:  Mol Divers       Date:  2014-05-04       Impact factor: 2.943

3.  Spectrofluorometric and molecular docking studies on the binding of curcumenol and curcumenone to human serum albumin.

Authors:  Omer Abdalla Ahmed Hamdi; Shevin Rizal Feroz; Jamil A Shilpi; El Hassane Anouar; Abdul Kadir Mukarram; Saharuddin B Mohamad; Saad Tayyab; Khalijah Awang
Journal:  Int J Mol Sci       Date:  2015-03-06       Impact factor: 5.923

4.  A Quantum Chemical and Statistical Study of Cytotoxic Activity of Compounds Isolated from Curcuma zedoaria.

Authors:  Omer Abdalla Ahmed Hamdi; El Hassane Anouar; Jamil A Shilpi; Zuhra Bashir Khalifa Al Trabolsy; Sharifuddin Bin Md Zain; Nur Shahidatul Shida Zakaria; Mohd Zulkefeli; Jean-Frédéric F Weber; Sri Nurestri A Malek; Syarifah Nur Syed Abdul Rahman; Khalijah Awang
Journal:  Int J Mol Sci       Date:  2015-04-27       Impact factor: 5.923

5.  Evaluation of antimicrobial activity of Curcuma longa rhizome extract against Staphylococcus aureus.

Authors:  Ankur Gupta; Surabhi Mahajan; Rajendra Sharma
Journal:  Biotechnol Rep (Amst)       Date:  2015-02-18

6.  Antitumour Effects of Isocurcumenol Isolated from Curcuma zedoaria Rhizomes on Human and Murine Cancer Cells.

Authors:  S Lakshmi; G Padmaja; P Remani
Journal:  Int J Med Chem       Date:  2011-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.